Rubbish old boy.
If Novartis were ditching msb for “commercial” reasons they would have just said those were the reasons. Bizarre you think they would lie about that. If anything, saying “commercial reasons” is easier that announcing to the world the data stinks.
Oh, there’s plenty of murky being posted by the cult. There’s always murk when there’s bad news to explain away.
What I was saying is misleading is the old nip’s pronunciation that, actually, msb were the one who pulled the pin on the partnership. They ditched Novartis! Crazy stuff.
Sorepocket the New CSL.
Novartis walked due to "sub par data"., page-136
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |